Delivery Order SPE2DB22D2206-SPE2DB25FEJ29

Award Date 11/21/24
Potential Completion Date 11/22/24
Potential Value $5.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $2,190.18, is a delivery order for the supply of Phenobarbital 130 mg/ml vials. The contract has an ultimate completion date of March 31, 2025 and is a firm fixed price arrangement. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued at...
This federal contract award, valued at $1,551.55, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of Phenobarbital 130 mg/ml vials, a medication commonly used in the treatment of seizure disorders. The contract has an ultimate completion date of March 6, 2024 and is a Firm Fixed Price arrangement. Amerisourcebergen holds a significant Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,776.56 firm fixed-price delivery order covers the supply of 130 mg/mL vials of the drug Phenobarbital. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order under Contract SPE2DX15D3026/SPE2DX24FUXDA with the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,241.12, is for the supply of PHENOBARBITAL 65 MG/ML VIAL. This delivery order does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,075.92, is a Firm Fixed Price Delivery Order for the supply of Phenobarbital 130 mg/ml vials. The contract has an ultimate completion date of May 21, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award is for the delivery of Phenobarbital 65 mg/ml vials to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a firm fixed price of $1,625.60 and an ultimate completion date of January 24, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves...
This federal contract award, valued at $1,719.12, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The contract is a delivery order against Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA, which has a ceiling value of $999,999,999 and runs through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $1,490.14 and is a Delivery Order with a Firm Fixed Price pricing type. The contract is for the supply of 4567850091 - PHENOBARBITAL 130 MG/ML VIALML. This appears to be part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This is a federal contract award (SPE2DX15D3006|SPE2DX25F01WP) issued by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,190.18 firm fixed-price delivery order is for the supply of 4567090412 - PHENOBARBITAL 130 MG/ML VIALML, with a performance period ending on January 30, 2025. The contract is not designated as a set-aside. Amerisourcebergen holds a larger...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,296.66 firm fixed-price delivery order is for the procurement of 4567673577 ! PHENOBARBITAL 130 MG/ML VIALML, with a completion date of March 25, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB25FEJ29
    Delivery Order

This federal contract award is a delivery order valued at $5,149.68 issued to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) Troop Support Medical. The award is for the supply of 4566516943 - Phenobarbital 130 mg/ml vials.

Amerisourcebergen is the prime contractor and a major pharmaceutical distributor that holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a broad range of medical commodities, including specialty medications, generic drugs, vaccines, and medical supplies, to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products.

This specific delivery order does not have a set-aside designation, indicating open competition. The contract has a firm fixed price pricing type and a period of performance through November 2024.

Generated 2/20/25, 9:29 AM